Deroy & Devereaux Private Investment Counsel Inc. Sells 48 Shares of UnitedHealth Group Incorporated $UNH

Deroy & Devereaux Private Investment Counsel Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,052 shares of the healthcare conglomerate’s stock after selling 48 shares during the quarter. Deroy & Devereaux Private Investment Counsel Inc.’s holdings in UnitedHealth Group were worth $328,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently added to or reduced their stakes in UNH. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. GAMMA Investing LLC lifted its holdings in UnitedHealth Group by 7.4% during the first quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock valued at $8,295,000 after purchasing an additional 1,089 shares in the last quarter. Exchange Traded Concepts LLC lifted its holdings in UnitedHealth Group by 49.0% during the first quarter. Exchange Traded Concepts LLC now owns 2,827 shares of the healthcare conglomerate’s stock valued at $1,481,000 after purchasing an additional 930 shares in the last quarter. Finally, Chicago Capital LLC raised its position in shares of UnitedHealth Group by 3.4% during the first quarter. Chicago Capital LLC now owns 1,027 shares of the healthcare conglomerate’s stock valued at $538,000 after buying an additional 34 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Bank of America lifted their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. Barclays lifted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Seventeen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $384.09.

UnitedHealth Group Trading Up 0.2%

UNH stock opened at $360.77 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a market capitalization of $326.73 billion, a price-to-earnings ratio of 15.63, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47. The firm’s fifty day simple moving average is $325.04 and its two-hundred day simple moving average is $347.17.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm earned $6.80 EPS. The company’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.